Insiders · Profile

AKKARAJU SRINIVAS

Director at ALUMIS · Director at Kalaris Therapeutics · Director at Scholar Rock · and 2 more. Filing since 12 May 2015. CIK 0001253170

Company
Date
Role
Action
Shares
Amount
Of holding
8 Sep 2026
Director
Bought
273,291
$2.90M
5.9%
8 Sep 2026
Director
Bought
273,290
$2.90M
13.5%
8 Sep 2026
Director
Sold at will
48,066
$507.02K
1.0%
8 Sep 2026
Director
Sold at will
48,065
$507.01K
2.3%
4 Sep 2026
Director
Bought
220,070
$2.46M
11.9%
4 Sep 2026
Director
Bought
220,070
$2.46M
4.9%
20 May 2026
Director
Bought
244,300
$1.18M
12.3%
9 Jan 2026
Director
Bought
588,235
$10.00M
46.5%
18 Dec 2025
Director
Bought
479,847
$5.00M
32.0%
5 Dec 2025
Director
Bought
186,377
$1.83M
17.3%
4 Dec 2025
Director
Bought
66,027
$540.10K
6.5%
3 Dec 2025
Director
Bought
100,000
$775.00K
11.0%
2 Dec 2025
Director
Bought
96,000
$724.80K
11.8%
1 Dec 2025
Director
Bought
86,350
$644.17K
11.8%
28 Nov 2025
Director
Bought
38,702
$295.68K
5.6%
26 Nov 2025
Director
Bought
48,537
$370.82K
7.5%
20 Nov 2025
Director
Bought
125,743
$905.35K
24.3%
19 Nov 2025
Director
Bought
137,772
$903.78K
36.3%
18 Nov 2025
Director
Bought
102,652
$621.04K
37.0%
17 Nov 2025
Director
Bought
914
$5.04K
0.3%
13 Nov 2025
Director
Bought
276,179
$1.45M
opened
7 Oct 2025
Director
Bought
29,599
$1.18M
5.9%
6 Oct 2025
Director
Bought
113,025
$4.37M
29.2%
3 Oct 2025
Director
Bought
387,414
$14.44M
opened
4 Sep 2025
Director
Bought
588,235
$15.00M
opened
5 May 2025
Director
Bought
160,370
$749.68K
4.7%
2 May 2025
Director
Bought
159,920
$727.64K
4.9%
13 Mar 2025
Director
Bought
600,000
$8.10M
11.8%
7 Oct 2024
Director
Sold on a plan
1,175,713
$34.39M
17.3%
16 Oct 2023
Director
Bought
2,189,781
$15.00M
47.6%
14 Feb 2023
Director
Bought
937,500
$15.00M
26.2%
12 May 2015
Director
Bought
320,000
$4.48M
20.7%
32 decisions on file.